tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
TBPH
Theravance Biopharma
RESEARCH TOOLSreports
Want to see TBPH full AI Analyst Report?

Theravance Biopharma (TBPH) Revenue

352 Followers
StatisticsMarket CapRevenue

Theravance Biopharma Revenue

Theravance Biopharma had a revenue of 17.70M in the quarter ending Mar 31, 2026, with -61.43%. This bring the company's revenue in the last twelve months to 109.78M, Decreased 2.15%. In the fiscal year ending Dec 31, 2025, Theravance Biopharma had annual revenue of 107.46M with 66.92% growth.
Revenue (ttm)
109.78M
Revenue Growth
68.20%
P/S Ratio
7.80
Revenue/Employee
$1,107,876
Employees
97
Market Cap
$838.25M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
107.46M43.08M+66.92%
Dec 31, 2024
64.38M6.96M+12.12%
Dec 31, 2023
57.42M6.08M+11.84%
Dec 31, 2022
51.35M-3.96M-7.17%
Dec 31, 2021
55.31M-16.55M-23.03%
Dec 31, 2020
71.86M-1.56M-2.12%
Dec 31, 2019
73.41M13.04M+21.61%
Dec 31, 2018
60.37M44.98M+292.37%
Dec 31, 2017
15.39M――